Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models

Abolhassani, Hossein; Eskandari, Alireza; Saremi Poor, Anita; Zarrabi, Ali; Khodadadi, Behnoosh; Karimifard, Sara; Sahrayi, Hamidreza; Bourbour, Mahsa; Tavakkoli Yaraki, Mohammad

doi:10.1016/j.ccr.2024.215754

Coordination Chemistry Reviews

2024

DOI: 10.1016/j.ccr.2024.215754

|View full text |Cite

Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models

Hossein Abolhassani,

Alireza Eskandari,

Anita Saremi Poor

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 271 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Synthesis, characterization, and applications of starch-based nano drug delivery systems for breast cancer therapy: A review

Mei,

Roopashree,

Altalbawy

et al. 2024

International Journal of Biological Macromolecules

View full text Add to dashboard Cite

Synthesis, characterization, and applications of starch-based nano drug delivery systems for breast cancer therapy: A review

Mei,

Roopashree,

Altalbawy

et al. 2024

International Journal of Biological Macromolecules

View full text Add to dashboard Cite

Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective

Razavi,

Soltani,

Mahmoudvand

et al. 2024

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

Myocardial infarction (MI) stands as a prominent contributor to global cardiovascular disease (CVD) mortality rates. Acute MI (AMI) can result in the loss of a large number of cardiomyocytes (CMs), which the adult heart struggles to replenish due to its limited regenerative capacity. Consequently, this deficit in CMs often precipitates severe complications such as heart failure (HF), with whole heart transplantation remaining the sole definitive treatment option, albeit constrained by inherent limitations. In response to these challenges, the integration of bio-functional materials within cardiac tissue engineering has emerged as a groundbreaking approach with significant potential for cardiac tissue replacement. Bioengineering strategies entail fortifying or substituting biological tissues through the orchestrated interplay of cells, engineering methodologies, and innovative materials. Biomaterial scaffolds, crucial in this paradigm, provide the essential microenvironment conducive to the assembly of functional cardiac tissue by encapsulating contracting cells. Indeed, the field of cardiac tissue engineering has witnessed remarkable strides, largely owing to the application of biomaterial scaffolds. However, inherent complexities persist, necessitating further exploration and innovation. This review delves into the pivotal role of biomaterial scaffolds in cardiac tissue engineering, shedding light on their utilization, challenges encountered, and promising avenues for future advancement. By critically examining the current landscape, we aim to catalyze progress toward more effective solutions for cardiac tissue regeneration and ultimately, improved outcomes for patients grappling with cardiovascular ailments.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models

Cited by 2 publications

References 271 publications

Synthesis, characterization, and applications of starch-based nano drug delivery systems for breast cancer therapy: A review

Synthesis, characterization, and applications of starch-based nano drug delivery systems for breast cancer therapy: A review

Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective

Contact Info

Product

Resources

About